Fidelity Disruptive Medicine ETF (FMED)
NASDAQ (NGS) NASDAQ (NGS) Primary Summary
FMED Chart
Innovative ETF Strategies That Are Paying Off This Summer
Exchange-traded fund (ETF) inflows reached an astonishing $1 trillion for the first half of 2026 alone, the latest sign that investors everywhere are continuing to lean heavily on these vehicles to simplify their experience and add built-in diversification to their portfolios. Unsurprisingly, the number of funds available continues to skyrocket, although many investors stick with major ETFs tracking the S&P or other prominent indexes instead of venturing into unique strategies.
Disruptive Healthcare Stocks ETF FMED Hits Milestone in June
While healthcare stocks may not always seem the most enticing, they've quietly surged over the last month. The active healthcare tech ETF, FMED, which focuses on industry disruptors, saw its June performance significantly leapfrog its overall YTD numbers.
2 ETFs That Capitalize on the “Silver Tsunami”
An aging population is leading to a profound demographic shift known as the “Silver Tsunami.” With more Baby Boomers reaching retirement age, the demand for senior living facilities and medicinal innovation is increasing.
Fidelity Disruptive Medicine ETF Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| AAL Avraham A. Levitan Glass Jacobson Investment Advisors LLC | 50 | $1,352.5 | $1,565.75 | $213.25 | 15.77% |
 Christopher C. Powers Farther Finance Advisors, LLC | 925 | $22,893.75 | $25,895.56 | $3,001.81 | 13.11% |
| CY Cathy Yasui Central Pacific Bank - Trust Division | 97 | $2,453 | $2,715.51 | $262.51 | 10.7% |
Fidelity Disruptive Medicine ETF (FMED) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Fidelity Disruptive Medicine ETF ever had a stock split?
Fidelity Disruptive Medicine ETF Profile
| NASDAQ (NGS) Exchange | US Country |
Overview
This company operates a fund focused on investing in disruptive medicine companies that challenge traditional healthcare systems through innovative solutions. The core investment strategy hinges on allocating at least 80% of its assets into securities of companies that are at the forefront of medical innovation. These entities either have in place or are in the process of developing non-conventional methods that aim to revolutionize the delivery of healthcare products and services. Fidelity's disruptive strategies are instrumental in identifying these pioneering developments, seeking out companies that have the potential to significantly alter and enhance current market practices, potentially displacing existing companies over time. The fund's portfolio is non-diversified, indicating a concentrated investment approach in the disruptive medicine sector.
Products and Services
- Investment in Disruptive Medicine Securities
- Fidelity's Disruptive Strategies
This service involves the allocation of the fund’s assets towards companies involved in groundbreaking healthcare innovations. By putting at least 80% of its investments into the securities of such entities, the fund aims to support and capitalize on the advancements these companies bring to the medicine and healthcare industry. The focus on disruptive medicine companies that are developing or have developed new approaches highlights the fund’s commitment to transformative healthcare solutions.
Utilizing Fidelity's expertise in identifying companies with innovative solutions, the fund taps into disruptive strategies that aim to invest in companies poised for significant growth. These strategies specifically target firms that are not only pioneering new products and services in healthcare but are also capable of disrupting existing markets and displacing incumbent players over time. This approach allows investors in the fund to potentially benefit from the accelerated growth and market transformation driven by these disruptive companies.
